Apogee Therapeutics Announces First Patient Dosed in Part B of Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis
Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolledPart A 16-week proof-of-concept data ...
Invivyd Announces Preliminary Fourth Quarter 2024 Financial Results, Strong Revenue Growth, and Reiterates Goal of Near-Term Profitability
PEMGARDA™ (pemivibart) net product revenue of $13.8 million, 48% growth over Q3 2024 net product revenue of $9.3 ...
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS ...
Daily22h
FDA Approves Symbravo for Acute Migraine Treatment
The US Food and Drug Administration FDA has approved Symbravo, an oral combination of meloxicam and rizatriptan, for the ...
Review: New Village Arts’ ‘Marie Curie’ a moving story of female friendship
In the early 20th century, two of Europe’s most famous women scientists had to fight the male establishment for lab space, teaching positions, fellowships and — most important — recognition for their ...
TheGamer on MSN16h
Final Fantasy 7’s Whispers And Other Video Game Characters I’d Love To Eat
Which is why, while playing Final Fantasy 7 Rebirth recently, I was surprised to feel myself experiencing hunger. The ...